Company ProfileGDMC, Genetic Design and Manufacturing Corporation, focuses on addressing key problems for cell, gene, and nucleic acid therapies by from design through scale-up to cGMP clinical material for our partners. These partners range from academic/clinical investigators, innovative start-ups, to clinical-stage growth companies, with whom we design modalities for manufacturability, conduct process development and manufacture drug product for clinical trials. GDMC’s differentiation includes its technology approach combining synthetic biology and machine learning for better product design and improved production platforms. The outcomes include robust scalable processes for manufacturing floor, reduced failed production rates, accelerated timelines for both process development and clinical trials, and smarter libraries for focused protein engineering.